30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
France Biotechnology & Medical Research

Theranexus SA (ALTHX)

Track

The most recent insider trading activity at Theranexus SA occurred on November 4, 2020. On this date, Thierry Lambert, the Chief Financial Officer, executed both a buy and a sell transaction. The buy transaction involved 1,481 shares valued at $9,768.84, while the sell transaction comprised 4,706 shares worth $60,593.74.
Stock chart
Ticker: ALTHX Exchange: PAR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Thierry Lambert
Directeur Administratif et Financier
1 buy, 1 sell — total 70,363 EUR
Buy 4 Nov 2020
Value €1,441,699.41 | Price 100.62 | Shares 50,540
Sale 4 Nov 2020
Value €1,321,367.92 | Price 169.18 | Shares 12,672
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-01-27 2020-11-04 B Purchase
Thierry Lambert

Directeur Administratif et Financier

Executive Director
50,540
100.62
€1,441,699 		50,540 100.62 €1,441,699
2021-01-27 2020-11-04 S Sale
Thierry Lambert

Directeur Administratif et Financier

Executive Director
12,672
169.18
€1,321,368 		12,672 169.18 €1,321,368
Explore more

More insider trading research around Theranexus SA

More insider trades in France
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe